Free Trial

Edap Tms (EDAP) Competitors

Edap Tms logo
$2.17 -0.03 (-1.36%)
As of 01/17/2025 04:00 PM Eastern

EDAP vs. SMTI, LUNG, DRTS, ELMD, ZYXI, INGN, NYXH, RCEL, CATX, and PROF

Should you be buying Edap Tms stock or one of its competitors? The main competitors of Edap Tms include Sanara MedTech (SMTI), Pulmonx (LUNG), Alpha Tau Medical (DRTS), Electromed (ELMD), Zynex (ZYXI), Inogen (INGN), Nyxoah (NYXH), AVITA Medical (RCEL), Perspective Therapeutics (CATX), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry.

Edap Tms vs.

Edap Tms (NASDAQ:EDAP) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

62.7% of Edap Tms shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 0.2% of Edap Tms shares are held by insiders. Comparatively, 54.1% of Sanara MedTech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Edap Tms received 328 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 61.96% of users gave Edap Tms an outperform vote while only 55.88% of users gave Sanara MedTech an outperform vote.

CompanyUnderperformOutperform
Edap TmsOutperform Votes
347
61.96%
Underperform Votes
213
38.04%
Sanara MedTechOutperform Votes
19
55.88%
Underperform Votes
15
44.12%

Edap Tms currently has a consensus price target of $19.00, indicating a potential upside of 775.58%. Sanara MedTech has a consensus price target of $47.00, indicating a potential upside of 44.00%. Given Edap Tms' higher possible upside, analysts clearly believe Edap Tms is more favorable than Sanara MedTech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edap Tms
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Sanara MedTech
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Sanara MedTech has lower revenue, but higher earnings than Edap Tms. Sanara MedTech is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edap Tms$65.42M1.23-$22.92M-$0.65-3.34
Sanara MedTech$64.99M4.39-$4.30M-$0.99-32.97

In the previous week, Edap Tms had 6 more articles in the media than Sanara MedTech. MarketBeat recorded 6 mentions for Edap Tms and 0 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 1.87 beat Edap Tms' score of 0.68 indicating that Sanara MedTech is being referred to more favorably in the news media.

Company Overall Sentiment
Edap Tms Positive
Sanara MedTech Very Positive

Sanara MedTech has a net margin of -10.71% compared to Edap Tms' net margin of -34.92%. Sanara MedTech's return on equity of -19.86% beat Edap Tms' return on equity.

Company Net Margins Return on Equity Return on Assets
Edap Tms-34.92% -44.21% -25.88%
Sanara MedTech -10.71%-19.86%-10.91%

Edap Tms has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500.

Summary

Sanara MedTech beats Edap Tms on 9 of the 16 factors compared between the two stocks.

Get Edap Tms News Delivered to You Automatically

Sign up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDAP vs. The Competition

MetricEdap TmsElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$80.51M$3.60B$5.34B$9.06B
Dividend YieldN/A1.74%5.13%4.02%
P/E Ratio-3.3418.6887.2517.10
Price / Sales1.2372.791,259.85138.34
Price / CashN/A41.1043.7535.97
Price / Book1.313.915.324.80
Net Income-$22.92M$96.59M$122.60M$224.91M
7 Day Performance3.33%3.48%0.88%1.90%
1 Month Performance0.46%6.30%4.81%5.08%
1 Year Performance-63.77%5.08%27.90%21.15%

Edap Tms Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDAP
Edap Tms
3.2559 of 5 stars
$2.17
-1.4%
$19.00
+775.6%
-62.3%$80.51M$65.42M-3.34230Short Interest ↓
SMTI
Sanara MedTech
2.4363 of 5 stars
$32.46
+0.7%
$47.00
+44.8%
-13.5%$283.73M$78.06M-32.7960News Coverage
Positive News
LUNG
Pulmonx
2.4397 of 5 stars
$7.05
+4.3%
$12.75
+80.9%
-50.8%$278.39M$79.30M-4.80250News Coverage
Positive News
DRTS
Alpha Tau Medical
2.3994 of 5 stars
$3.70
+14.6%
$8.00
+116.2%
+27.4%$258.72MN/A-8.6080Short Interest ↑
ELMD
Electromed
N/A$30.47
+2.4%
N/A+223.5%$257.72M$57.06M42.32160
ZYXI
Zynex
3.8281 of 5 stars
$7.77
-0.8%
$14.00
+80.2%
-22.1%$247.44M$193.67M51.801,100Positive News
INGN
Inogen
3.3099 of 5 stars
$10.33
+8.2%
$7.00
-32.2%
+95.0%$246.04M$331.52M-4.591,030Analyst Forecast
Short Interest ↓
Positive News
NYXH
Nyxoah
3.5612 of 5 stars
$9.33
+0.9%
$17.00
+82.2%
+170.7%$232.69M$5.08M-4.99110Positive News
RCEL
AVITA Medical
1.6377 of 5 stars
$8.82
-3.5%
$18.00
+104.1%
-37.8%$231.24M$60.04M-3.96130Short Interest ↑
CATX
Perspective Therapeutics
2.9993 of 5 stars
$3.40
-2.9%
$15.14
+345.4%
N/A$229.80M$1.43M0.0070Analyst Forecast
PROF
Profound Medical
2.6171 of 5 stars
$7.45
-1.6%
$14.25
+91.3%
-5.6%$223.71M$8.98M-5.56150

Related Companies and Tools


This page (NASDAQ:EDAP) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners